{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:46:09Z","timestamp":1778888769864,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11255-021-02862-2","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T10:03:11Z","timestamp":1618653791000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of sirtuin 1 (SIRT1) levels in autosomal dominant polycystic kidney disease"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-0525","authenticated-orcid":false,"given":"Pervin","family":"Ozkan Kurtgoz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-7435","authenticated-orcid":false,"given":"Suleyman","family":"Karakose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6052-4645","authenticated-orcid":false,"given":"Cigdem Damla","family":"Cetinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7821-8275","authenticated-orcid":false,"given":"Edip","family":"Erkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1646-2811","authenticated-orcid":false,"given":"Ibrahim","family":"Guney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,17]]},"reference":[{"key":"2862_CR1","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ (2008) Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 359:1477\u20131485","journal-title":"N Engl J Med"},{"key":"2862_CR2","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.ekir.2020.06.002","volume":"5","author":"ME Ters","year":"2020","unstructured":"Ters ME, Zhou X, Lepping RJ, Lu P, Karcher RT, Mahnken JD et al (2020) Biological efficacy and safety of niacinamide in patients with ADPKD. Kidney Int Rep 5:1271\u20131279","journal-title":"Kidney Int Rep"},{"key":"2862_CR3","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1681\/ASN.2017111218","volume":"29","author":"M Morigi","year":"2018","unstructured":"Morigi M, Perico L, Benigni A (2018) Sirtuins in renal health and disease. J Am Soc Nephrol 29:1799\u20131809","journal-title":"J Am Soc Nephrol"},{"key":"2862_CR4","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1101\/gad.1467506","volume":"20","author":"MC Haigis","year":"2006","unstructured":"Haigis MC, Guarente LP (2006) Mammalian sirtuins emerging roles in physiology, aging, and calorie restriction. Genes Dev 20:2913\u20132921","journal-title":"Genes Dev"},{"key":"2862_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/843786","author":"YJ Dong","year":"2014","unstructured":"Dong YJ, Liu N, Xiao Z et al (2014) Renal protective effect of Sirtuin 1. J Diabetes Res. https:\/\/doi.org\/10.1155\/2014\/843786","journal-title":"J Diabetes Res"},{"key":"2862_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.7326\/0003-4819-152-9-201005040-00006","volume":"152","author":"AD Rule","year":"2010","unstructured":"Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK et al (2010) The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 152:561\u2013567","journal-title":"Ann Intern Med"},{"key":"2862_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/archinternmed.2008.605","volume":"169","author":"CY Hsu","year":"2009","unstructured":"Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS (2009) Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169:342\u2013350","journal-title":"Arch Intern Med"},{"key":"2862_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.1172539","volume":"328","author":"L Fontana","year":"2010","unstructured":"Fontana L, Partridge L, Longo VD (2010) Extending healthy life span: from yeast to humans. Science 328:321\u2013326","journal-title":"Science"},{"key":"2862_CR9","first-page":"131","volume":"124","author":"A Guclu","year":"2016","unstructured":"Guclu A, Erdur FM, Turkmen K (2016) The emerging role os sirtuin 1 in cellular metabolism, diabetes mellitus, diabetic kidney disease and hypertension. Exp Clin Endocrinol Diabetes 124:131\u2013139","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2862_CR10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.4239\/wjd.v5.i6.894","volume":"5","author":"K Turkmen","year":"2014","unstructured":"Turkmen K, Karagoz A, Kucuk A (2014) Sirtuins as novel players in the pathogenesis of diabetes mellitus. World J Diabetes 5:894\u2013900","journal-title":"World J Diabetes"},{"key":"2862_CR11","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1172\/JCI64401","volume":"123","author":"X Zhou","year":"2013","unstructured":"Zhou X, Fan LX, Sweeney WEJR et al (2013) Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. J Clin Invest 123:3084\u20133098","journal-title":"J Clin Invest"},{"key":"2862_CR12","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","volume":"343","author":"D Ravine","year":"1994","unstructured":"Ravine D, Gibson RN, Walker RG et al (1994) Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343:824\u2013827","journal-title":"Lancet"},{"key":"2862_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-017-2628-6","author":"L Peintner","year":"2017","unstructured":"Peintner L, Borner C (2017) Role of apoptosis in the development of autosomal dominant polycystic kidney disease (ADPKD). Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-017-2628-6","journal-title":"Cell Tissue Res"},{"key":"2862_CR14","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1111\/j.1523-1755.2004.66003.x","volume":"66","author":"A Persu","year":"2004","unstructured":"Persu A, Duyme M, Pirson Y et al (2004) Comparison between siblings and twins supports a role for modifier genes in ADPKD. Kidney Int 66:2132\u20132136","journal-title":"Kidney Int"},{"key":"2862_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/1573402111309010008","volume":"9","author":"MV Irazabal","year":"2013","unstructured":"Irazabal MV, Torres VE (2013) Experimental therapies and ongoing clinical trials to slow down progression of ADPKD. Curr Hypertens Rev 9:44\u201359","journal-title":"Curr Hypertens Rev"},{"key":"2862_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1056\/NEJM199507063330104","volume":"333","author":"D Woo","year":"1995","unstructured":"Woo D (1995) Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333:18\u201325","journal-title":"N Engl J Med"},{"key":"2862_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0092-8674(92)90123-T","volume":"69","author":"GI Evan","year":"1992","unstructured":"Evan GI, Wyllie AH, Gilbert CS et al (1992) Induction of apoptosis in fibroblasts by c-Myc protein. Cell 69:119\u2013128","journal-title":"Cell"},{"key":"2862_CR18","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1681\/ASN.2013020176","volume":"24","author":"LX Fan","year":"2013","unstructured":"Fan LX, Zhou X, Sweeney WE et al (2013) Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts. J Am Soc Nephrol 24:2010\u20132022","journal-title":"J Am Soc Nephrol"},{"key":"2862_CR19","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1084\/jem.186.11.1873","volume":"186","author":"M Trudel","year":"1997","unstructured":"Trudel M, Lanoix J, Barisoni L et al (1997) C-myc\u2013induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J Exp Med 186:1873\u20131884","journal-title":"J Exp Med"},{"key":"2862_CR20","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.4161\/cc.4.11.2185","volume":"4","author":"CL Edelstein","year":"2005","unstructured":"Edelstein CL (2005) What is the role of tubular epithelial cell apoptosis in polycystic kidney disease (PKD)? Cell Cycle 4:1550\u20131554","journal-title":"Cell Cycle"},{"key":"2862_CR21","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bbadis.2011.01.006","volume":"1812","author":"B Goilav","year":"2011","unstructured":"Goilav B (2011) Apoptosis in polycystic kidney disease. Biochim Biophys Acta 1812:1272\u20131280","journal-title":"Biochim Biophys Acta"},{"key":"2862_CR22","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.biocel.2004.03.012","volume":"36","author":"PD Wilson","year":"2004","unstructured":"Wilson PD (2004) Polycystic kidney disease: new understanding in the pathogenesis. Int J Biochem Cell B 36:1868\u20131873","journal-title":"Int J Biochem Cell B"},{"key":"2862_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nephro.2013.11.009","volume":"10","author":"AA Adlouni","year":"2014","unstructured":"Adlouni AA, Hertig A (2014) Vitamin B3 to prevent autosomal dominant polycystic kidney disease. Nephrol Ther 10:183\u2013185. https:\/\/doi.org\/10.1016\/j.nephro.2013.11.009","journal-title":"Nephrol Ther"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02862-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-021-02862-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02862-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T11:38:30Z","timestamp":1641382710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-021-02862-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,17]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2862"],"URL":"https:\/\/doi.org\/10.1007\/s11255-021-02862-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,17]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was accepted (Decision number 41901325-050.99) by the Ethics Committee of Karatay University. Signed informed consent form was taken from all patients and control cases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approvement"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}